EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Understanding the selectivity of nonsteroidal anti-inflammatory drugs for cyclooxygenases using quantum crystallography and electrostatic interaction energy

S Pawlędzio, M Ziemniak, X Wang, K Woźniak iD, M Malinska iD

IUCrJ · 2025

DOI: 10.1107/s2052252525000053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUCrJ, 2025. Verfasst von S Pawlędzio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Cyclooxygenase 1, Cyclooxygenase Inhibitors, Cyclooxygenase 2. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quantum crystallography methods have been employed to investigate complex formation between nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase (COX) enzymes, with particular focus on the COX-1 and COX-2 isoforms. This study analyzed the electrostatic interaction energies of selected NSAIDs (flurbiprofen, ibuprofen, meloxicam and celecoxib) with the active sites of COX-1 and COX-2, revealing significant differences in binding profiles. Flurbiprofen exhibited the strongest interactions with both COX-1 and COX-2, indicating its potent binding affinity. Celecoxib and meloxicam showed a preference for COX-2, consistent with their known selectivity for this isoform, while ibuprofen showed comparable interaction energies with both isoforms, reflecting its nonselective inhibition pattern. Key amino-acid residues, including Arg120, Arg/His513 and Tyr355, were identified as critical determinants of NSAID selectivity and binding affinity. The findings highlight the complex interplay between interaction energy and selectivity, suggesting that while electrostatic interactions play a fundamental role, additional factors such as enzyme dynamics and the hydrophobic effect also contribute to the therapeutic efficacy and safety profiles of NSAIDs. These insights provide valuable guidance for the rational design of NSAIDs with enhanced therapeutic benefits and minimized adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 1Cyclooxygenase InhibitorsCyclooxygenase 2Static ElectricityIbuprofenMeloxicamCelecoxibHumansFlurbiprofen

Stichwörter der Autor:innen

EPMMNSAIDscelecoxibexact potential/multipole modelflurbiprofenibuprofenmeloxicammultipole modelprotein crystallography

Substanzen

Anti-Inflammatory Agents, Non-SteroidalIbuprofenMeloxicamCyclooxygenase 1CelecoxibFlurbiprofenCyclooxygenase InhibitorsCyclooxygenase 2

Autor:innen und Institutionen

  • Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.
  • Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, 02-093 Warsaw, Poland.

ORCID-Profile: K Woźniak, M Malinska

Förderung

  • Narodowe Centrum Nauki

Zitieren

APA

Pawlędzio, S., Ziemniak, M., Wang, X., Woźniak, K., & Malinska, M. (2025). Understanding the selectivity of nonsteroidal anti-inflammatory drugs for cyclooxygenases using quantum crystallography and electrostatic interaction energy. IUCrJ. https://doi.org/10.1107/s2052252525000053

Vancouver

Pawlędzio S, Ziemniak M, Wang X, Woźniak K, Malinska M. Understanding the selectivity of nonsteroidal anti-inflammatory drugs for cyclooxygenases using quantum crystallography and electrostatic interaction energy. IUCrJ. 2025. doi:10.1107/s2052252525000053

BibTeX
@article{Pawldzio2025,
  author = {Pawlędzio, S and Ziemniak, M and Wang, X and Woźniak, K and Malinska, M},
  title = {Understanding the selectivity of nonsteroidal anti-inflammatory drugs for cyclooxygenases using quantum crystallography and electrostatic interaction energy},
  journal = {IUCrJ},
  year = {2025},
  doi = {10.1107/s2052252525000053}
}
Kostenlos starten →